Literature DB >> 10749377

Expression of cyclin-dependent kinase inhibitors during corneal wound repair.

J D Zieske1.   

Abstract

During corneal epithelial wound repair, cells migrating to cover the wound area exhibit a drastic reduction in proliferative activity. In contrast, cells distal to the original wound exhibit a greatly enhanced level of proliferative activity. At least 90% of the basal cells in limbal and peripheral corneal epithelia synchronously progress through the cell cycle. The question addressed in this article is whether cyclin-dependent kinase inhibitors play a role in the alterations in proliferative activity seen during corneal wound repair. These inhibitors specifically block cells in the G1-phase of the cell cycle. Two families of cyclin-dependent kinase inhibitors have been identified. The CIP/KIP family includes p21, p27, and p57, while the INK4 family consists of p16. p15. p18. and pI9. At least five of these inhibitors are present in the corneal epithelium. The expression of two of these, p15 and p27. is dramatically altered during wound repair, suggesting that they may be involved in the changes in cell proliferation observed during corneal wound healing.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10749377     DOI: 10.1016/s1350-9462(99)00018-x

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  15 in total

1.  Targeted inhibition of p57 and p15 blocks transforming growth factor beta-inhibited proliferation of primary cultured human limbal epithelial cells.

Authors:  Zhuo Chen; De-quan Li; Louis Tong; Paul Stewart; Claire Chu; Stephen C Pflugfelder
Journal:  Mol Vis       Date:  2006-08-23       Impact factor: 2.367

2.  Expression of cell cycle-regulatory proteins, MIB-1, p16, p53, and p63, in squamous cell carcinoma of conjunctiva: not associated with human papillomavirus infection.

Authors:  Shih-Ming Jung; Hsin-Chiung Lin; Pao-Hsien Chu; Hsien-Hwa Wu; Tzu-Fang Shiu; Shang Lang Huang; Chyong-Huey Lai
Journal:  Virchows Arch       Date:  2005-12-03       Impact factor: 4.064

3.  Assessment of the anticancer mechanism of ferulic acid via cell cycle and apoptotic pathways in human prostate cancer cell lines.

Authors:  Canan Eroğlu; Mücahit Seçme; Gülseren Bağcı; Yavuz Dodurga
Journal:  Tumour Biol       Date:  2015-06-30

4.  Targeted deletion of AP-2alpha leads to disruption in corneal epithelial cell integrity and defects in the corneal stroma.

Authors:  Dhruva J Dwivedi; Giuseppe F Pontoriero; Ruth Ashery-Padan; Shelley Sullivan; Trevor Williams; Judith A West-Mays
Journal:  Invest Ophthalmol Vis Sci       Date:  2005-10       Impact factor: 4.799

5.  Corneal antifibrotic switch identified in genetic and pharmacological deficiency of vimentin.

Authors:  Paola Bargagna-Mohan; Riya R Paranthan; Adel Hamza; Chang-Guo Zhan; Do-Min Lee; Kyung Bo Kim; Daniel L Lau; Cidambi Srinivasan; Keiko Nakayama; Keiichi I Nakayama; Harald Herrmann; Royce Mohan
Journal:  J Biol Chem       Date:  2011-11-22       Impact factor: 5.157

6.  TGF-β-target genes are differentially regulated in corneal epithelial cells and fibroblasts.

Authors:  Xiaoqing Guo; Audrey E K Hutcheon; Jennifer A Tran; James D Zieske
Journal:  New Front Ophthalmol       Date:  2017-01-30

7.  Role of thrombospondin-1 in repair of penetrating corneal wounds.

Authors:  José Tomás Blanco-Mezquita; Audrey E K Hutcheon; James D Zieske
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-17       Impact factor: 4.799

Review 8.  Redox control of the cell cycle in health and disease.

Authors:  Ehab H Sarsour; Maneesh G Kumar; Leena Chaudhuri; Amanda L Kalen; Prabhat C Goswami
Journal:  Antioxid Redox Signal       Date:  2009-12       Impact factor: 8.401

9.  Essential role for Pbx1 in corneal morphogenesis.

Authors:  Mark J Murphy; Bozena K Polok; Daniel F Schorderet; Michael L Cleary
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-09-24       Impact factor: 4.799

10.  Nerve growth factor promotes corneal epithelial migration by enhancing expression of matrix metalloprotease-9.

Authors:  Tomas Blanco-Mezquita; Carmen Martinez-Garcia; Rui Proença; James D Zieske; Stefano Bonini; Alessandro Lambiase; Jesus Merayo-Lloves
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-06-04       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.